Gold nanoparticles join fight against advanced melanoma in early safety trial

NCT ID NCT07562841

Recruiting now Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen May 02, 2026 · Last updated May 08, 2026 · Updated 3 times

Summary

This early-phase study tests whether a new gold nanoparticle treatment (Au-TMP) is safe when injected into tumors, followed by radiation and an immunotherapy drug (Toripalimab). It involves 6 adults with advanced melanoma that cannot be surgically removed. The main goal is to check for side effects and find a safe dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

West China Hospital, Sichuan University
NOT_YET_RECRUITING

Chengdu, Sichuan, 610041, China
West China Hospital, Sichuan University
RECRUITING

Chengdu, Sichuan, 610041, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED MELANOMA